Cargando…
Radio-Iodide Treatment: From Molecular Aspects to the Clinical View
SIMPLE SUMMARY: This year marks the 80th commemoration of the first time that radio-iodide treatment (RAI) was used. RAI is one of the most effective targeted internal radiation anticancer therapies ever devised and it has been used for many decades, however, a thorough understanding of the underlyi...
Autores principales: | De la Vieja, Antonio, Riesco-Eizaguirre, Garcilaso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957486/ https://www.ncbi.nlm.nih.gov/pubmed/33673669 http://dx.doi.org/10.3390/cancers13050995 |
Ejemplares similares
-
Validation of dynamic risk stratification and impact of BRAF in risk assessment of thyroid cancer, a nation-wide multicenter study
por: Pérez-Fernández, Laura, et al.
Publicado: (2023) -
ß-catenin signaling is required for RAS-driven thyroid cancer through PI3K activation
por: Sastre-Perona, Ana, et al.
Publicado: (2016) -
Impaired microRNA processing by DICER1 downregulation endows thyroid cancer with increased aggressiveness
por: Ramírez-Moya, Julia, et al.
Publicado: (2019) -
RAS Subcellular Localization Inversely Regulates Thyroid Tumor Growth and Dissemination
por: García-Ibáñez, Yaiza, et al.
Publicado: (2020) -
Basolateral Sorting of the Sodium/Iodide Symporter Is Mediated by Adaptor Protein 1 Clathrin Adaptor Complexes
por: Koumarianou, Petrina, et al.
Publicado: (2022)